Performance of an Interferon-γ Release Assay-Based Test for Cell-Mediated Immunity to SARS-CoV-2

    February 2023 in “ Frontiers in Immunology
    Luís Fonseca Brito, Silvia Tödter, Julian Kottlau, Kathrin Cermann, Anthea Spier, Elina Petersen, Ines Schäfer, Raphael Twerenbold, Martin Aepfelbacher, Marc Lütgehetmann, Felix R. Stahl
    Studysummary In this study, researchers reported that a newly developed interferon-γ release assay for cell-mediated immunity to SARS-CoV-2 nucleocapsid peptides demonstrated high sensitivity and specificity, making it a robust tool for routine diagnostic tests and potentially useful in predicting clinical outcomes after pathogen re-exposure.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results